{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T05:35:58Z","timestamp":1793684158483,"version":"4.5.1"},"reference-count":25,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2008,7,7]],"date-time":"2008-07-07T00:00:00Z","timestamp":1215388800000},"content-version":"vor","delay-in-days":2757,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[2000,12,19]]},"abstract":"<jats:p>Recent reports suggest that low testosterone:androstenedione (T:A) ratio following hCG stimulation may be a useful method of diagnosing 17\u03b2\u2010hydroxysteroid dehydrogenase\u20103 (17 \u03b2HSD3) deficiency. The aim of this study was to establish the range of T:A ratios in cases of undermasculinization with proven aetiologies other than 17 \u03b2HSD3.<\/jats:p><jats:p>Register\u2010based study of cases of male undermasculinization reported to a central database by clinicians.<\/jats:p><jats:p>Amongst the 421 cases of under\u2010masculinization, 114 cases had testosterone and androstenedione levels before and after hCG stimulation. Of the 114, there were 18 cases of abnormal testes, 17 cases of complete androgen insensitivity syndrome (CAIS), 68 cases of partial AIS (PAIS). Of the 17 cases of CAIS, 13 had evidence of androgen receptor (AR) dysfunction; in the PAIS cohort, 26 cases had evidence of AR dysfunction.<\/jats:p><jats:p>Analysis of T:A ratios in the above cohorts and comparison of these ratios to those in a group of previously described cases of 17 \u03b2HSD3 deficiency with a mean ratio of 0\u00b74 (SD: 0\u00b72)<\/jats:p><jats:p>The median age (range) for the CAIS, PAIS and abnormal testes cohort was 1\u00b725\u2003years (0\u00b706\u201316\u00b75), 0\u00b77\u2003years (0\u00b702\u201340\u00b73) and 0\u00b75\u2003years (0\u00b704\u20136\u00b75), respectively. In CAIS, the median T:A rose from 0\u00b74 (0\u00b71 to 8\u00b70) to 4\u00b75 (0\u00b75\u201316\u00b77); in PAIS, median T:A rose from 0\u00b77 (0\u00b71 to 15) to 3\u00b79 (0\u00b73\u201320\u00b75); in cases with abnormal testes, median T:A rose from 0\u00b74 (0\u00b71 to 5\u00b76) to 0\u00b76 (0\u00b71\u20133\u00b76). The median post\u2010hCG T:A ratio was significantly lower in the abnormal testes cohort (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030\u00b701). None of the cases of AIS with <jats:italic>AR<\/jats:italic> mutation had a low T:A ratio. Only four out of 84 cases diagnosed as AIS had a T:A ratio less than 0\u00b78 (mean +\u200a2SD in 17\u03b2HSD3 deficiency). In one of the four cases, the T:A ratio rose to 3\u00b75 following a prolonged hCG stimulation test.<\/jats:p><jats:p>Deficiency of 17\u03b2HSD3 should be considered in 46XY undermasculinization if the post\u2010hCG stimulation T:A ratio is less than 0\u00b78. However, low T:A ratios may be encountered in conditions such as abnormal testes. Before embarking on mutational analysis, we would also recommend careful evaluation for testicular dysgenesis including a prolonged hCG stimulation test in cases with a low T:A ratio.<\/jats:p>","DOI":"10.1046\/j.1365-2265.2000.01166.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T10:47:17Z","timestamp":1047379637000},"page":"697-702","source":"Crossref","is-referenced-by-count":70,"title":["The testosterone:androstenedione ratio in male undermasculinization"],"prefix":"10.1111","volume":"53","author":[{"given":"S.","family":"Faisal Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ieuan A.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,7,7]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.85.2.658"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/adc.80.4.324"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1054\/cupe.2000.0089"},{"key":"e_1_2_6_5_1","first-page":"1","article-title":"Clinical features and gender assignment in cases of male undermasculinisation: the role for a masculinisation score","volume":"84","author":"Ahmed. S.F.","year":"2000","journal-title":"British Journal of Urology International"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(97)80063-7"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/1043-2760(96)00034-3"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03350158"},{"key":"e_1_2_6_9_1","first-page":"775","article-title":"Etiologic evaluation of male pseudohermaphroditism in infancy and childhood","volume":"138","author":"Berkovitz G.D.","year":"1984","journal-title":"American Journal of Diseases in Childhood"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.84.12.4713"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1981.tb00360.x"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-68-2-477"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1984.tb00063.x"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-49-1-132"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1159\/000183784"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.83.8.2855"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1136\/adc.82.1.54"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1210\/edrv-16-3-271"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-39-2-370"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-32-5-604"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1978.tb01498.x"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-57-2-421"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-60-4-639"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1136\/adc.77.4.305"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.1976.tb04932.x"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0950-351X(98)80478-3"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2265.2000.01166.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2265.2000.01166.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2265.2000.01166.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T11:54:36Z","timestamp":1698580476000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2265.2000.01166.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,12,19]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2000,12,19]]}},"alternative-id":["10.1046\/j.1365-2265.2000.01166.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2265.2000.01166.x","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,12,19]]}}}